Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

25.0%

10 terminated/withdrawn out of 40 trials

Success Rate

72.2%

-14.3% vs industry average

Late-Stage Pipeline

13%

5 trials in Phase 3/4

Results Transparency

115%

30 of 26 completed trials have results

Key Signals

30 with results10 terminated

Enrollment Performance

Analytics

N/A
13(56.5%)
Phase 4
5(21.7%)
Phase 2
5(21.7%)
23Total
N/A(13)
Phase 4(5)
Phase 2(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (40)

Showing 20 of 40 trials
NCT06540079Not ApplicableActive Not Recruiting

BIOTRONIK Conduction System Pacing With the Solia Lead - Solia CSP S

Role: lead

NCT07118358Not ApplicableNot Yet Recruiting

BIOTRONIK Investigation of the LivIQ Leadless Pacemaker System

Role: lead

NCT04175626Completed

Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions

Role: lead

NCT04190186Not ApplicableCompleted

Hybrid Ablation Plus Medical Therapy for Persistent Atrial Fibrillation

Role: collaborator

NCT05251363Not ApplicableCompleted

BIOTRONIK Conduction System Pacing With the Solia Lead

Role: lead

NCT03884608Completed

Analysis of Both Sex and Device Specific Factors on Outcomes in Patients with Non-Ischemic Cardiomyopathy

Role: lead

NCT04683718Not ApplicableActive Not Recruiting

A First in Human Feasibility Study to Evaluate the Safety and Effectiveness of the BIOTRONIK Prospera SCS System with HomeStream Remote Management

Role: lead

NCT03594266Not ApplicableCompleted

Comparison of the Effects of Two Spinal Cord Stimulation (SCS) Therapies on Subject Reported Pain (BENEFIT-02)

Role: lead

NCT03361189Phase 2Terminated

Specialized Pacing for Patients With Congenital Heart Disease

Role: collaborator

NCT02389946Not ApplicableCompleted

Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions

Role: lead

NCT04076917Terminated

Assessment of the Utility of BIOMONITOR to Identify Atrial Fibrillation (AF) in Ablation Candidates Using Precise AF Detection

Role: lead

NCT04870281Terminated

Atrial Fibrillation Associated With Heart Failure Treated by BIOTRONIK's CRT-DX System

Role: lead

NCT02693262Not ApplicableCompleted

Comparing Rate Response With CLS Versus Accelerometer ICD Settings in Heart Failure Patients With BIOTRONIK CRT-Ds

Role: collaborator

NCT02290028Not ApplicableTerminated

Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads

Role: collaborator

NCT03155724Not ApplicableCompleted

QP ExCELs: MultiPole Pacing (MPP) Sub-Study

Role: lead

NCT03103503Terminated

Plexa ICD Lead Registry

Role: lead

NCT02243696Terminated

Protego DF4 Post Approval Registry

Role: lead

NCT01791127Terminated

Safety and Performance Study of the Siello S Pacing Lead

Role: lead

NCT00810264Completed

Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar

Role: lead

NCT02682251Not ApplicableCompleted

Engaging Patients in Heart Failure Management

Role: collaborator